Investigational drug delivers mixed results for uncontrolled blood pressure

The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, a protein that turns into the hormone that regulates blood pressure—caused a significant and sustained drop in…

Continue Reading

News Source: medicalxpress.com